Sessa Capital (Master), L.P. Sab Biotherapeutics, Inc. (SABS) insider trading activity

SABS Quotes by TradingView

Sessa Capital (Master), L.P. is Director of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 4.58 Million shares of SABS, which is worth approximately $18.6 Million. The most recent transaction as insider was on Nov 24, 2023, when has been sold 4,584,571 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.58M
0% 3M change
n/a 12M change
Total Value Held $18.6 Million

Sessa Capital (Master), L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 24 2023
BUY
Exercise of conversion of derivative security
-
4,584,571 Added 50.0%
4,584,571 Common Stock

Also insider at

PRVB
Provention Bio, Inc. Healthcare
> 10% Shareholder
SC(

Sessa Capital (Master), L.P.

Director
New York, NY

Track Institutional and Insider Activities on SABS

Follow SAB Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SABS shares.

Notify only if

Insider Trading

Get notified when an Sab Biotherapeutics, Inc. insider buys or sells SABS shares.

Notify only if

News

Receive news related to SAB Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SABS